MDxHealth and QUT bluebox say their planned liquid biopsy epigenetic assay will evaluate abnormal DNA methylation changes

MDxHealth, QUT Partner to Develop Oral Cancer Liquid Biopsy Assay

The saliva test will evaluate abnormal DNA methylation changes to indicate whether a patient may be at higher risk of developing cancer
Source: Stas_Uvarov/Getty Images

Quidel Whooping Cough MDx Gets FDA Clearance

The diagnostic provides for the qualitative detection and differentiation of Bordetella pertussis and Bordetella parapertussis nucleic acids
Source: © Mopic/

Veritas’ myGenome to Apply Fabric Genomics’ Annotation Technology

Fabric Annotations appends gene and impact information, as well as multiple predictive scores and links to literature evidence.
One of the major scientific crusades in oncology has been to identify and validate biomarkers associated with recurrent breast cancer. [iStock / royaltystockphoto]

Case Study: Breast Cancer YAPI (Yet Another Prognostic Indicator) Revisited: ASCO Recommendations

Using biomarker assays guide decision-making processes and standardize clinical approaches for women with early-stage invasive breast cancer
Source: yodiyim/Getty Images

Accumulation of Inherited Common Genetic Variants Implicated in Migraines

Researchers show that common genetic variants combined to contribute to familial migraine to a greater degree than individual rare variants
Quartz-made Nanopillars of 250-nm diameter were arrayed inside nanoslit region of 100-nm high and applied for ultrafast microRNA extraction from nucleic acids mixture. [Noritada Kaji]

Nanobiodevice Could Become Rapid Cancer Molecular Diagnostic

Scientific collaboration yields a pioneering nanobiodevice that can isolate cancer biomarkers quickly with high resolution.
Clinical OMICs Magazine: Volume 3

Cancer Diagnostics Leverage Decreasing Cost of Sequencing

The cancer diagnostic landscape has evolved significantly since the first companion diagnostic was launched to detect overexpression of the HER2 gene in breast cancer...
A recent study involving multiple research institutes found significant variations both in sequencing and evaluation results in some of the reports on cancer mutations. [Centro Nacional de Analisis Genómico

Improving Cancer Genome Analysis

Oncologists are increasingly using information obtained from investigations of the tumor genome to find individualized therapies for patients. They specifically search the hereditary information...
Whole exome sequencing is becoming more available to patients and will help them distill the sequencing data to candidate genes and link them with therapies. [NCI]

Mining Whole Exome Sequencing Data for Better Cancer Therapies

New tool interprets raw data of whole exome tumor sequencing and matches the cancer's unique genetics to FDA-approved targeted treatments.
Source: © olly/Fotolia

Dako, Amgen Expand Cancer CDx Collaboration

Dako, an Agilent Technologies company specializing in providing cancer diagnostics, said today it has again expanded a three-year-old collaboration with Amgen focused on companion...
Scroll Up